- Home
- PKBK vs VYGR Comparison
PKBK vs VYGR Comparison
Compare PKBK & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PKBK
- VYGR
- Stock Information
- Founded
- PKBK 1999
- VYGR 2013
- Country
- PKBK United States
- VYGR United States
- Employees
- PKBK N/A
- VYGR N/A
- Industry
- PKBK Major Banks
- VYGR Biotechnology: Pharmaceutical Preparations
- Sector
- PKBK Finance
- VYGR Health Care
- Exchange
- PKBK Nasdaq
- VYGR Nasdaq
- Market Cap
- PKBK 269.2M
- VYGR 231.9M
- IPO Year
- PKBK N/A
- VYGR 2015
- Fundamental
- Price
- PKBK $20.75
- VYGR $4.69
- Analyst Decision
- PKBK
- VYGR Strong Buy
- Analyst Count
- PKBK 0
- VYGR 8
- Target Price
- PKBK N/A
- VYGR $16.71
- AVG Volume (30 Days)
- PKBK 27.7K
- VYGR 789.3K
- Earning Date
- PKBK 10-21-2025
- VYGR 11-11-2025
- Dividend Yield
- PKBK 3.46%
- VYGR N/A
- EPS Growth
- PKBK 42.58
- VYGR N/A
- EPS
- PKBK 2.56
- VYGR N/A
- Revenue
- PKBK $66,879,999.00
- VYGR $42,580,000.00
- Revenue This Year
- PKBK N/A
- VYGR N/A
- Revenue Next Year
- PKBK N/A
- VYGR $107.10
- P/E Ratio
- PKBK $8.24
- VYGR N/A
- Revenue Growth
- PKBK 3.52
- VYGR N/A
- 52 Week Low
- PKBK $16.94
- VYGR $2.65
- 52 Week High
- PKBK $24.29
- VYGR $8.28
- Technical
- Relative Strength Index (RSI)
- PKBK 32.36
- VYGR 62.56
- Support Level
- PKBK $21.01
- VYGR $4.32
- Resistance Level
- PKBK $21.37
- VYGR $5.06
- Average True Range (ATR)
- PKBK 0.42
- VYGR 0.29
- MACD
- PKBK -0.17
- VYGR 0.02
- Stochastic Oscillator
- PKBK 0.00
- VYGR 64.59
About PKBK Parke Bancorp Inc.
Parke Bancorp Inc operates as a commercial bank providing personal and financial services to individuals and small to mid-sized businesses in various states of the USA. The bank offers services such as loan products, deposit services, and other financial products through its retail branches and other channels to its customers. Its lending businesses are commercial real estate lending, residential real estate lending, and construction lending among others. The Company operates one reportable segment of business, community banking.
About VYGR Voyager Therapeutics Inc.
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.